/
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom.
Mentions
1 mention · latest on 30 Sept 2026
See which tracked investors hold Recursion Pharmaceuticals, Inc. →Ownership and position changes on OwnershipTrace
| Life Extension per Token | - | 30 Sept 2026 |